All News

Treatment with tagraxofusp yielded high response rates in patients with blastic plasmacytoid dendritic cell neoplasm.

Top news of the day from across the health care landscape.

Suzanne Soliman, PharmD, founded the Pharmacist Mom Group on Facebook, and it has since grown to be 1 of the most active on the popular social media platform, with more than 2 million posts last year alone.

A study in 2008 showed that approximately 5.2% of US adults age 18-80 years used benzodiazepines.

Using genetic testing for women newly diagnosed with breast cancer can decrease the high cost of chemotherapy use in the first year of care.

Top news of the day from across the health care landscape.

Although the prevalence of LEMS in children is not known, the overall prevalence is estimated to be 3 per million individuals worldwide, according to the FDA.

Amifampridine (Ruzurgi, Jacobus) is the first treatment approved specifically for pediatric patients 6 to 17 years of age with Lambert-Eaton myasthenic syndrome.

When applying for the grant for Realo Discount Drug’s Transition to Wellness Program, Christina Nunemacher's goal was to show that involving pharmacists in the hospital discharge process could lower readmission rates.

A certain type of DNA rearrangement that is rarely tested for may be a predictor of prognosis in multiple myeloma.

Ado-trastuzumab emtansine (Kadcyla) is currently the only antibody-drug conjugate approved for the treatment of HER2-positive early and metastatic breast cancer.

Prior to this approval, there were no available treatments for ATTR-CM, only symptom management and, in rare cases, heart transplant.

Top news of the day from across the health care landscape.

How did a man with low sperm county get his wife pregnant?

Dapagliflozin is a selective sodium‑glucose cotransporter-2 (SGLT-2) inhibitor that is combined with a dipeptidyl peptidase‑4 (DPP‑4) inhibitor, saxagliptin; and metformin hydrochloride extended release.

Transthyretin amyloid cardiomyopathy is a rare and fatal disease for which there are no previously approved treatments.

Can omega 3 oils calm inflamation?

Pivotal phase 3 trial results show benefits for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy Ellipta) in patients with uncontrolled asthma compared with standard FF/VI (Breo Ellipta) therapy.

In the first and largest study of its kind, researchers from the University of British Columbia (UBC) and Vancouver Coastal Health Research Institute aimed to assess mortality associated with beta interferons for the treatment of MS.

The FDA rapidly reviewed and approved Genentech’s application under the FDA’s Real-Time Oncology Review (RTOR) and Assessment Aid pilot programs, leading to an approval 12 weeks after completing the submission.

Officials with the FDA have approved AstraZeneca’s dapagliflozin, saxagliptin and metformin hydrochloride (Qternmet XR) extended release tablets for adults with type 2 diabetes.

Results of the recent study, published in The Lancet, support the benefits of early testing and treatment for HIV, as well as the message of Prevention Access Campaign’s U=U (undetectable equals untransmittable) initiative.

A molecular switch in the skin cells may cause increased susceptibility to autoimmunity in women.

Measles cases are increasing at an alarming rate, and the antivaccination movement has helped bring back this potentially deadly disease that was once eliminated in the United States.

Teva Pharmaceutical Industries has launched a generic version of Gilead’s Letairis (ambrisentan) Tablets, 5 mg and 10 mg, in the United States.

The approved generic treatment is therapeutically equivalent to Novartis’ Pataday Ophthalmic Solution, 0.2%, according to Alembic.

The sNDA was granted Priority Review and accepted under the agency's Real-Time Oncology Review pilot program, which aims to make the review of oncology drugs more efficient by allowing the FDA access to clinical trial data before the information is formally submitted to the agency.

The sNDA was granted Priority Review and accepted under the agency's Real-Time Oncology Review pilot program, which aims to make the review of oncology drugs more efficient by allowing the FDA access to clinical trial data before the information is formally submitted to the agency.

The influenza vaccine for the 2019-2020 flu season will look different than it has for the past few seasons.

The study authors believe that the modification of teriflunomide and the development of new DHODH inhibitors is urgent for drug-resistant epilepsy patients